Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 374

1.

Screening for colorectal neoplasms. A comparison of the fecal occult blood test and endoscopic examination.

Letsou G, Ballantyne GH, Zdon MJ, Zucker KA, Modlin IM.

Dis Colon Rectum. 1987 Nov;30(11):839-43.

PMID:
3677957
2.

Evaluation of the occult blood test in screening for colorectal neoplasms. A prospective study using flexible endoscopy.

Reilly JM, Ballantyne GH, Fleming FX, Zucker KA, Modlin IM.

Am Surg. 1990 Mar;56(3):119-23.

PMID:
2316930
3.

One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380.

N Engl J Med. 2001 Aug 23;345(8):555-60.

4.

Colonoscopic detection of early colorectal cancers. Impact of a surgical endoscopy service.

Longo WE, Ballantyne GH, Modlin IM.

Ann Surg. 1988 Feb;207(2):174-8.

5.

Relative sensitivity of the fecal occult blood test and flexible sigmoidoscopy in detecting polyps.

Demers RY, Stawick LE, Demers P.

Prev Med. 1985 Jan;14(1):55-62.

PMID:
4034514
6.

Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.

Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG.

J Natl Cancer Inst. 1993 Aug 18;85(16):1311-8.

PMID:
8340943
7.

Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.

Vijan S, Hwang EW, Hofer TP, Hayward RA.

Am J Med. 2001 Dec 1;111(8):593-601.

PMID:
11755501
8.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
9.

The relative value of fecal occult blood tests and flexible sigmoidoscopy in screening for large bowel neoplasia.

Rozen P, Ron E, Fireman Z, Hallak A, Grossman A, Baratz M, Rattan J, Gilat T.

Cancer. 1987 Nov 15;60(10):2553-8.

PMID:
3664435
10.

Feasibility of fecal occult-blood testing for detection of colorectal neoplasia: debits and credits.

Winawer SJ, Miller DG, Schottenfeld D, Leidner SD, Sherlock P, Befler B, Stearns MW Jr.

Cancer. 1977 Nov;40(5 Suppl):2616-9.

PMID:
922702
11.

Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.

Manus B, Brägelmann R, Armbrecht U, Stolte M, Stockbrügger RW.

Eur J Cancer Prev. 1996 Feb;5(1):49-55.

PMID:
8664809
12.
13.

Stool occult blood screening for colorectal cancer.

Frame PS, Kowulich BA.

J Fam Pract. 1982 Dec;15(6):1071-5.

PMID:
7142926
14.

Accuracy and value of the Hemoccult test in symptomatic patients.

Leicester RJ, Lightfoot A, Millar J, Colin-Jones DG, Hunt RH.

Br Med J (Clin Res Ed). 1983 Feb 26;286(6366):673-4.

15.

Clinicopathologic significance of immunohistochemical fecal occult blood test in subjects receiving bidirectional endoscopy.

Liu HH, Huang TW, Chen HL, Wang TH, Lin JT.

Hepatogastroenterology. 2003 Sep-Oct;50(53):1390-2.

PMID:
14571744
16.

The earlier detection of colorectal cancers: a preliminary report of the results of the Occult Blood Study.

Gilbertsen VA, McHugh R, Schuman L, Williams SE.

Cancer. 1980 Jun 1;45(11):2899-2901.

PMID:
7379021
17.

Screening for colorectal cancer.

Diehl AK.

J Fam Pract. 1981 Apr;12(4):625-32.

PMID:
7205165
18.

Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.

Sharma VK, Corder FA, Raufman JP, Sharma P, Fennerty MB, Howden CW.

Am J Gastroenterol. 2000 Aug;95(8):2068-73.

PMID:
10950059
19.

[Screening test for colorectal cancer. Practical experiences with fecal testing for occult blood. 2: Rate of a false-negative occult blood test].

Schellenberger U, Raabe A, Erler K.

Z Arztl Fortbild (Jena). 1987;81(20):1057-9. German. No abstract available.

PMID:
3433823
20.

Supplemental Content

Support Center